A study analysing long-term efficacy and tolerability of add-on Stiripentol treatment in different forms of refractory epilepsies
Latest Information Update: 20 Jan 2021
At a glance
- Drugs Stiripentol (Primary) ; Antiepileptic drugs; Clobazam
- Indications Dravet syndrome; Epilepsy; Generalised epilepsy; Generalised seizures; Partial epilepsies; Tonic-clonic epilepsy
- Focus Adverse reactions; Therapeutic Use
- 20 Jan 2021 New trial record
- 08 Dec 2020 Results presented at the 74th Annual Meeting of the American Epilepsy Society